Hair Loss Treatments & Cellular Scalp Restoration in Manasquan, NJ

Advanced Follicular Science, Laser-Assisted Drug Delivery & Regenerative Scalp Medicine

Medically Reviewed & Directed by Dr. Corina Ianculovici, DNP, FAAMFM, ABAAHP
Founder & Clinical Director, Mirelle Institute for Longevity & Regenerative Medicine
Fellow, American Academy of Anti-Aging Medicine | Faculty Fellow, Cellular Medicine Association

Clinical Focus: Regenerative Dermatology, Functional Endocrinology & Non-Surgical Follicular Restoration


Follicular miniaturization, diffuse crown thinning, and chronic shedding are biological markers of microvascular insufficiency, hormonal shifts, and cellular senescence. At the Mirelle Institute for Longevity & Regenerative Medicine, we reject superficial cosmetic covers. Our clinician-guided hair loss treatments target alopecia at the root through functional cellular revitalization.


By integrating non-ablative 1927nm fractional laser-assisted drug delivery (LADD), autologous PRP/PRFM biotherapy, and bio-identical signaling peptides, we restore the scalp microenvironment to reawaken dormant hair follicles and extend active anagen growth phases.


Clinical Modalities & Targeted Hair Restoration

Evidence-Based Clinical Hair Restoration Modalities


1. KeraLase® Laser Hair Restoration: Needle-Free Follicle Stimulation


  • Mechanism & Technology: Utilizes the Lutronic Ultra® 1927nm non-ablative fractional thulium laser to generate tens of thousands of microscopic, non-thermal micro-channels in the scalp stratum corneum without disrupting tissue integrity or cutting hair strands.


  • Targeted Drug Delivery: Immediately saturates open micro-channels with the proprietary KeraFactor® Peptide Complex (KFP™)—nanoliposome-encapsulated, bio-identical growth factors engineered specifically to bypass inhibitory scalp proteins (like TGF-β1) and signal dermal papilla stem cells.


  • Primary Indications: Non-invasive treatment for female pattern hair loss, early androgenetic alopecia, postpartum telogen effluvium, perimenopausal thinning, and post-hair-transplant graft preservation. Zero needles, zero pain, and zero social downtime.


2. Autologous Platelet-Rich Plasma (PRP) & PRFM Scalp Injections


  • Mechanism & Technology: Double-spin centrifugal isolation of the patient’s whole blood to harvest concentrated, bioactive autologous platelets suspended within a fibrin matrix (PRFM).


  • Biological Pathway: Degranulating platelets deliver a high-concentration cascade of essential signaling proteins—including PDGF (Platelet-Derived Growth Factor), VEGF (Vascular Endothelial Growth Factor), and TGF-β—directly into the follicular bulb. This spurs local angiogenesis (new capillary growth), calms localized perifollicular inflammation, and prompts miniaturized follicles into active vascularized regrowth.


  • Primary Indications: Norwood II–IV male pattern recession, diffuse Ludwig-scale female thinning, and synergistic combination cycles with fractional thulium laser treatments.


3. AnteAGE MD® Exosome & Cytokine Signaling Therapy


  • Mechanism & Technology: Ethically sourced, laboratory-cultured biosignaling cytokines and anti-inflammatory growth factors derived from human bone marrow mesenchymal stem cells.


  • Cellular Action: Neutralizes chronic scalp senescence and downregulates pro-inflammatory cytokines that trigger stress shedding. It reconditions the follicular niche, tightens dermal sheath anchorage, and increases individual hair shaft diameter.


  • Primary Indications: Scalp conditioning, micro-needling adjuncts, bridging therapy between clinical procedures, and regenerative support for scalp inflammatory conditions.


Schedule Hair Loss Consultation


Comparative Modality Analysis: AnteAGE MD™ vs. KeraLase®

AnteAGE MD™ Cytokine Therapy

  • Primary Delivery: Topical transdermal absorption & microneedling infusion
  • Active Biological Agent: Bone-marrow-derived stem cytokines & cellular growth factors
  • Target Pathology: Scalp senescent inflammation & microenvironmental health
  • Procedure Profile: 100% non-invasive, no energy device required
  • Treatment Cadence: Daily at-home topical or in-clinic maintenance


KeraLase® Laser Protocol

  • Primary Delivery: 1927nm fractional laser micro-channeling
  • Active Biological Agent: Bio-identical KeraFactor® targeted peptide complex (KFP™)
  • Target Pathology: Follicle receptor stimulation & microvascular revitalization
  • Procedure Profile: Mild scalp warmth/tingling; 15-minute needle-free session
  • Treatment Cadence: Structured series: 6 sessions spaced 2–4 weeks apart


Clinician-Curated Systemic Support & Photobiomodulation


True follicular rejuvenation requires addressing internal drivers alongside topical stimulation:


  • Nutrafol® Clinical Formulations: Standardized, medical-grade nutraceuticals formulated to downregulate cortisol-induced stress shedding and DHT-driven follicular miniaturization from within.
  • Hormone Optimization & Longevity Diagnostics: For women experiencing perimenopause hair thinning or men undergoing andropause, we balance underlying thyroid, estrogen, progesterone, and androgen levels through functional medicine diagnostics and menopause care.
  • HAIRgevityPro Peptide Serum (GHK-Cu): Clinical-strength copper tripeptide-1 complex to upregulate collagen production in the scalp extracellular matrix and anchor hair roots.
  • Medical Photobiomodulation (Theradome® Cold Laser): Coherent, medical-grade cold laser diodes engineered to target cytochrome c oxidase within follicular mitochondria, boosting ATP synthesis and blood perfusion between in-office KeraLase® or PRP procedures.

Multi-Targeted At-Home & Systemic Synergies

Nutrafol® Clinical Formulations


Scientific Rationale:

Multi-targeted nutraceutical therapy formulated with standardized botanicals to downregulate stress-induced shedding and DHT-driven miniaturization from within.


Order Nutrafol Online

KeraFactor® Scalp Care Complex



Scientific Rationale:

Nanoliposome-encapsulated growth factors that deliver high-concentration bio-identical proteins directly to dormant follicles to sustain in-office treatment results.

Order KeraFactor Online

HAIRgevityPro Peptide Serum (GHK-Cu)

Scientific Rationale:

Clinical copper tripeptide-1 complex that upregulates subcutaneous follicle anchorage, stimulates collagen synthesis, and expands hair shaft diameter.

Order HAIRgevityPro Online

Medical Photobiomodulation: Clinical Maintenance & Membership Support

Unlike standard LED devices, Theradome® utilizes medical-grade coherent cold laser diodes engineered to target cytochrome c oxidase within follicular mitochondria. This photobiomodulation process stimulates cellular ATP production, enhances microvascular perfusion, and counteracts oxidative dormancy in weakened hair follicles.

At Mirelle Institute, we utilize clinical laser phototherapy to protect and amplify clinical results. It serves as an active biological bridge between in-office KeraLase® or PRP/PRFM procedures, maintaining sustained scalp stimulation throughout your restoration cycle.

Clinical photobiomodulation therapy is integrated as an exclusive maintenance benefit within select Mirelle Hair Longevity Memberships and comprehensive in-office treatment protocols.


Clinical Demonstration: Inside a KeraLase® Treatment Session



Watch as we perform non-ablative 1927nm fractional laser micro-channeling followed by immediate topical delivery of concentrated KeraFactor® peptides. The entire treatment is gentle, needle-free, and completed in under 20 minutes with zero downtime.